CHANGES IN BIOMARKER STATUS AFTER NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER

被引：0
|
作者：
Matsumoto, A. [1 ]
Takahashi, M. [1 ]
Hayashida, T. [1 ]
Hirose, S. [2 ]
Jinno, H. [1 ]
Kitagawa, Y. [1 ]
机构：
[1] Keio Univ, Sch Med, Dept Surg, Tokyo 160, Japan
[2] Keio Univ, Sch Med, Tokyo, Japan
来源：
BREAST | 2013年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S64 / S64
页数：1
相关论文
共 50 条
  • [21] The Changes of Molecular Markers Between Before and After Neoadjuvant Chemotherapy in Breast Cancer
    Kim, T. H.
    Yoo, H. M.
    Choi, J. Y.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S122 - S122
  • [22] The effect of prolonged cold ischemia time on breast cancer biomarker expression after neoadjuvant chemotherapy
    Ghlichloo, Ida
    Shi, Wangpan Jackson
    Fadare, Oluwole
    PATHOLOGY RESEARCH AND PRACTICE, 2025, 266
  • [23] The Prognostic Effect of Changes in Tumor Stage and Nodal Status After Neoadjuvant Chemotherapy in Each Primary Breast Cancer Subtype
    Hayashi, Naoki
    Takahashi, Yuko
    Matsuda, Naoko
    Tsunoda, Hiroko
    Yoshida, Atsushi
    Suzuki, Koyu
    Nakamura, Seigo
    Yamauchi, Hideko
    CLINICAL BREAST CANCER, 2018, 18 (02) : E219 - E229
  • [24] Changes in HER2 status after neoadjuvant treatment of breast cancer
    Skalova, H.
    Dundr, P.
    Povysil, C.
    Pribylova, O.
    Petruzelka, L. B.
    Tvrdik, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [25] Nomogram for predicting axillary lymph node status after neoadjuvant chemotherapy in breast cancer
    Wang, Mengshen
    Wang, Mozhi
    Wang, Zhenning
    Song, Yongxi
    Gao, Peng
    Wang, Pengliang
    Wang, Chong
    Yu, Xueting
    Wei, Fengheng
    Guo, Jingyi
    Xu, Yingying
    TRANSLATIONAL CANCER RESEARCH, 2020, 9 (11) : 7054 - 7064
  • [26] Prognostic Significance of Biomarker Discordance in Breast Cancer Patients with Neoadjuvant Chemotherapy
    Matsumoto, Akiko
    Yoshikawa, Mio
    Takahashi, Yoko
    Jinno, Hiromitsu
    ANNALS OF ONCOLOGY, 2017, 28
  • [27] Prospective early response imaging biomarker for neoadjuvant breast cancer chemotherapy
    Lee, Kutei C.
    Moffat, Bradford A.
    Schott, Anne F.
    Layman, Rachel
    Ellingworth, Steven
    Juliar, Rebecca
    Khan, Amjad P.
    Helvie, Mark
    Meyer, Charles R.
    Chenevert, Thomas L.
    Rehemtulla, Alnawaz
    Ross, Brian D.
    CLINICAL CANCER RESEARCH, 2007, 13 (02) : 443 - 450
  • [28] Prognostic significance of biomarker discordance in breast cancer patients with neoadjuvant chemotherapy
    Matsumoto, A.
    Yoshikawa, M.
    Jinno, H.
    ANNALS OF ONCOLOGY, 2017, 28 : 19 - 19
  • [29] Metabolic biomarker signature for predicting the effect of neoadjuvant chemotherapy of breast cancer
    Lin, Xiaojie
    Xu, Rui
    Mao, Siying
    Zhang, Yuzhu
    Dai, Yan
    Guo, Qianqian
    Song, Xue
    Zhang, Qingling
    Li, Li
    Chen, Qianjun
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7 (22)
  • [30] Discordance in Immunohistochemical Status of Breast Cancer Post Neoadjuvant Chemotherapy
    Sanjit Kumar Agrawal
    Sanjoy Chatterjee
    Indu Arun
    Rosina Ahmed
    Indian Journal of Surgical Oncology, 2017, 8 (2) : 245 - 246
12345